A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease

NCT03716570 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
24
Enrollment
INDUSTRY
Sponsor class

Stopped Affiliated study NCT03318523 did not meet its primary outcome measure of change from baseline measured by Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and did not demonstrate efficacy on secondary outcome measures

Conditions

Interventions

Sponsor

Biogen